Martin Kerschensteiner
Klinikum der Universität München (LMU) & BMC
Martin Kerschensteiner is listed as Klinikum der Universität München (LMU) & BMC. Martin spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Felgenhauer-Preisträger-Symposium: Immunmechanismen und Bildgebung der MS-Progression”).
Compiled from published conference agendas; not yet confirmed by Martin. Is this you? Claim this profile.
About
Martin Kerschensteiner is the Chair for Neurosciences and Clinical Neuroimmunology and the Director of the Institute of Clinical Neuroimmunology at the Ludwig-Maximilians University in Munich. He received his medical training at the RWTH Aachen and Ludwig-Maximilians Universitiy (LMU) in Munich and performed his MD thesis at the Max-Planck Institute of Neurobiology. He received clinical training at the Department of Neurology of the LMU Munich and postdoctoral training at the Brain Research Institute of ETH Zurich, at Washington University in St. Louis and at Harvard University. After returning to Germany as a junior group leader, he was promoted to Associate Professor in 2008 and to Full Professor and Chair of the Institute of Clinical Neuroimmunology at LMU Munich in 2013. Professor Kerschensteiner`s research focuses on understanding the mechanisms of tissue damage and repair in neuroinflammatory conditions and the development of neuroprotective and regenerative treatment strategies.
Sessions at 1 conference
DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026
- Felgenhauer-Preisträger-Symposium: Immunmechanismen und Bildgebung der MS-Progression Speaker · 5 November 2026